Chlamydia pneumoniae effector chlamydial outer protein N sequesters fructose bisphosphate aldolase A, providing a benefit to bacterial growth

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Ishida, Kasumi ^a,b   Matsuo, Junji ^a   Yamamoto, Yoshimasa ^c,d,e   Yamaguchi, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JAPAN INTERNATIONAL COOPERATION AGENCY   (Japan)

^e OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Chlamydia pneumoniae; Chlamydial outer protein N; Effectors; Type III secretion

Indexed keywords

BACTERIAL PROTEIN; CHLAMYDIAL OUTER PROTEIN N; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUTATHIONE TRANSFERASE; GLYCOLYTIC ENZYME; OUTER MEMBRANE PROTEIN; RECOMBINANT ENZYME; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACTIN FILAMENT; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GEL FILTRATION CHROMATOGRAPHY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GLYCOLYSIS; HELA CELL LINE; HEP 2 CELL LINE; HOST CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MICROTUBULE ASSEMBLY; MOLECULAR SIZE; NONHUMAN; PROTEIN FAMILY; PROTEIN STRUCTURE; WESTERN BLOTTING; WILD TYPE; CELL LINE; CHLAMYDIA PNEUMONIAE; CHLAMYDIASIS; METABOLISM; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS D/UW-3/CX; CHLAMYDIAE; CHLAMYDOPHILA PNEUMONIAE;

BACTERIAL OUTER MEMBRANE PROTEINS; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GLYCOLYSIS; HUMANS;

EID: 84923865124     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-014-0330-3     Document Type: Article

References (43)

1. Blasi F, Tarsia P, Aliberti S: Chlamydophila pneumoniae. Clin Microbiol Infect 2009, 15(1):29-35.
2. Belland RJ, Ouellette SP, Gieffers J, Byrne GI: Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 2001, 6(2):117-127.
3. Gottlieb SL, Berman SM, Low N: Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? J Infect Dis 2010, 201(Suppl 2):S156-S167.
4. Malik A, Jain S, Rizvi M, Shukla I, Hakim S: Chlamydia trachomatis infection in women with secondary infertility. Fertil Steril 2009, 91(1):91-95.
5. Hahn DL, Schure A, Patel K, Childs T, Drizik E, Webley W: Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. PLoS One 2012, 7(4):e35945.
6. Abdelrahman YM, Belland RJ: The chlamydial developmental cycle. FEMS Microbiol Rev 2005, 29(5):949-959.
7. Abromaitis S, Stephens RS: Attachment and entry of Chlamydia have distinct requirements for host protein disulfide isomerase. PLoS Pathog 2009, 5(4):e1000357.
8. Hybiske K, Stephens RS: Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A 2007, 104(27):11430-11435.
9. Betts-Hampikian HJ, Fields KA: The chlamydial type III secretion mechanism: revealing cracks in a tough Nut. Front Microbiol 2010, 1:114.
10. Carayol N, Tran Van Nhieu G: Tips and tricks about Shigella invasion of epithelial cells. Curr Opin Microbiol 2013, 16(1):32-37.
11. van der Heijden J, Finlay BB: Type III effector-mediated processes in Salmonella infection. Future Microbiol 2012, 7(6):685-703.
12. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ, Carabeo RA, Hackstadt T: A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 2004, 101(27):10166-10171.
13. Subtil A, Parsot C, Dautry-Varsat A: Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol Microbiol 2001, 39(3):792-800.
14. Fields KA, Hackstadt T: Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol Microbiol 2000, 38(5):1048-1060.
15. Enninga J, Rosenshine I: Imaging the assembly, structure and activity of type III secretion systems. Cell Microbiol 2009, 11(10):1462-1470.
16. Botteaux A, Sory MP, Biskri L, Parsot C, Allaoui A: MxiC is secreted by and controls the substrate specificity of the Shigella flexneri type III secretion apparatus. Mol Microbiol 2009, 71(2):449-460.
17. Martinez-Argudo I, Blocker AJ: The Shigella T3SS needle transmits a signal for MxiC release, which controls secretion of effectors. Mol Microbiol 2010, 78(6):1365-1378.
18. Plano GV, Schesser K: The Yersinia pestis type III secretion system: expression, assembly and role in the evasion of host defenses. Immunol Res 2013, 57(1-3):237-245.
19. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, Sory MP, Stainier I: The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 1998, 62(4):1315-1352.
20. Ferracci F, Schubot FD, Waugh DS, Plano GV: Selection and characterization of Yersinia pestis YopN mutants that constitutively block Yop secretion. Mol Microbiol 2005, 57(4):970-987.
21. Herrmann M, Schuhmacher A, Mühldorfer I, Melchers K, Prothmann C, Dammeier S: Identification and characterization of secreted effector proteins of Chlamydophila pneumoniae TW183. Res Microbiol 2006, 157(6):513-524.
22. Ho TD, Starnbach MN: The Salmonella enterica serovar typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells. Infect Immun 2005, 73(2):905-911.
23. Archuleta TL, Du Y, English CA, Lory S, Lesser C, Ohi MD, Ohi R, Spiller BW: The Chlamydia effector chlamydial outer protein N (CopN) sequesters tubulin and prevents microtubule assembly. J Biol Chem 2011, 286(39):33992-33998.
24. Huang J, Lesser CF, Lory S: The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth. Nature 2008, 456(7218):112-115.
25. Ishida K, Kubo T, Saeki A, Yamane C, Matsuo J, Yimin, Nakamura S, Hayashi Y, Kunichika M, Yoshida M, Takahashi K, Hirai I, Yamamoto Y, Shibata K, Yamaguchi H: Chlamydophila pneumoniae in human immortal Jurkat cells and primary lymphocytes uncontrolled by interferon-γ. Microbes Infect 2013, 15(3):192-200.
26. Yamazaki T, Matsuo J, Nakamura S, Oguri S, Yamaguchi H: Effect of Ureaplasma parvum co-incubation on Chlamydia trachomatis maturation in human epithelial HeLa cells treated with interferon-γ. J Infect Chemother 2014, 20(8):460-464.
27. Kobayashi M, Ishida K, Matsuo J, Nakamura S, Nagasawa A, Motohashi K, Yao T, Hirai I, Yamamoto Y, Suzuki H, Shimizu C, Matsuno K, Yamaguchi H: Chlamydophila pneumoniae attachment and infection in low proteoglycan expressing human lymphoid Jurkat cells. Microb Pathog 2011, 51(3):209-216.
28. Gnoatto N, Lotufo RF, Matsuda M, Penna V, Marquezini MV: Expression of cell-surface heparan sulfate proteoglycans in human cyclosporin-induced gingival overgrowth. J Periodontal Res 2007, 42(6):553-558.
29. Marone M, Mozzetti S, De Ritis D, Pierelli L, Scambia G: Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proced Online 2001, 3:19-25.
30. Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, Oka M: Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol 2008, 33(4):725-731.
31. 2 treatment is associated with cell proliferation via the JNK signaling pathway in colon cancer cells. Int J Oncol 2012, 41 (5):1744-1750.
32. Everett KD, Bush RM, Andersen AA: Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999, Pt 2:415-440.
33. Nawrotek A, Guimarães BG, Velours C, Subtil A, Knossow M, Gigant B: Biochemical and Structural Insights into Microtubule Perturbation by CopN from Chlamydia pneumoniae. J Biol Chem 2014, pii:jbc.M114.568436.
34. Saka HA, Thompson JW, Chen YS, Kumar Y, Dubois LG, Moseley MA, Valdivia RH: Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms. Mol Microbiol 2011, 82(5):1185-1203.
35. Wang J, Morris AJ, Tolan DR, Pagliaro L: The molecular nature of the F-actin binding activity of aldolase revealed with site-directed mutants. J Biol Chem 1996, 271(12):6861-6865.
36. O'Reilly G, Clarke F: Identification of an actin binding region in aldolase. FEBS Lett 1993, 321(1):69-72.
37. Merkulova M, Hurtado-Lorenzo A, Hosokawa H, Zhuang Z, Brown D, Ausiello DA, Marshansky V: Aldolase directly interacts with ARNO and modulates cell morphology and acidic vesicle distribution. Am J Physiol Cell Physiol 2011, 300(6):C1442-C1455.
38. Du S, Guan Z, Hao L, Song Y, Wang L, Gong L, Liu L, Qi X, Hou Z, Shao S: Fructose-bisphosphate aldolase a is a potential metastasis-associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration. PLoS One 2014, 9(1):e85804.
39. Ritterson Lew C, Tolan DR: Aldolase sequesters WASP and affects WASP/Arp2/3-stimulated actin dynamics. J Cell Biochem 2013, 114(8):1928-1939.
40. Buscaglia CA, Penesetti D, Tao M, Nussenzweig V: Characterization of an aldolase-binding site in the Wiskott-Aldrich syndrome protein. J Biol Chem 2006, 281 (3):1324-1331.
41. Pollard TD: The cytoskeleton, cellular motility and the reductionist agenda. Nature 2003, 422(6933):741-745.
42. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M: The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem 2007, 282 (50):36321-36329.
43. Chambers MC, Song KH, Schneider DS: Listeria monocytogenes infection causes metabolic shifts in Drosophila melanogaster. PLoS One 2012, 7(12):e50679.